相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines
Marco Cavaleri et al.
LANCET (2021)
Vaccinology in the post-COVID-19 era
Rino Rappuoli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China
Chathika K. Weerasuriya et al.
BMC MEDICINE (2021)
New tuberculosis vaccines: advances in clinical development and modelling
C. K. Weerasuriya et al.
JOURNAL OF INTERNAL MEDICINE (2020)
The global prevalence of latent tuberculosis: a systematic review and meta-analysis
Adam Cohen et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Immunization: vital progress, unfinished agenda
Peter Piot et al.
NATURE (2019)
Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
D. R. Tait et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Malaria vaccine: WHO position paper, January 2016-Recommendations World Health Organization
VACCINE (2018)
Mind the gap: jumping from vaccine licensure to routine use
Katherine L O'Brien et al.
LANCET (2016)
Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines
Rebecca C. Harris et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries
Gwenan M. Knight et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)